Lexagene Holdings Inc 5XS2-FF:Frankfurt Stock Exchange

RT Quote | Exchange | EUR
Last | 02/26/21 CET
0.722quote price arrow down-0.008 (-1.10%)
52 week range
0.27 - 0.97

...

Loading . . .

KEY STATS

  • Open0.722
  • Day High0.722
  • Day Low0.722
  • Prev Close0.73
  • 52 Week High0.97
  • 52 Week High Date02/11/21
  • 52 Week Low0.27
  • 52 Week Low Date04/03/20
  • Market Cap101.41M
  • Shares Out114.36M
  • 10 Day Average Volume11,357.58
  • Dividend-
  • Dividend Yield-
  • Beta
  • 1 Year % Change6.18

RATIOS/PROFITABILITY

  • EPS (TTM)-0.08
  • P/E (TTM)-9.03
  • Fwd P/E (NTM)-
  • EBITDA (MRQ)-
  • ROE (MRQ)-
  • Revenue (MRQ)-
  • Gross Margin (MRQ)-
  • Net Margin (MRQ)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest Lexagene Holdings Inc News

There is no recent news for this security.

Latest 5XS2-FF News From Our Partners

There is no recent news for this security.

QUOTE FINDER

Profile

MORE
LexaGene Holdings, Inc. is a Canada-based molecular diagnostics company. The Company develops genetic analyzers for pathogen detection and other molecular markers for on-site testing in veterinary diagnostics, food safety and for use in open-access markets, including clinical research, agricultural testing and biodefense. It offers MiQLab genetic analyzer. The MiQLab genetic analyzer offers automated pathogen detection and customized testing. The MiQLab genetic analyzer draws...
John Regan
Chairman
Daryl Rebeck
President
Jeffrey Mitchell
Chief Financial Officer
Address
500 Cummings Ctr Ste 4550
Beverly, MA
01915-6534
United States